Guardant Health and Quest Diagnostics will collaborate to offer Guardant’s Shield blood-based colorectal cancer test through ...

Quest Diagnostics will soon begin offering a new blood-based in-vitro diagnostic test for Alzheimer’s. The disease affects nearly 7 million Americans. The Lumipulse G pTau 217/β-Amyloid 1-42 Plasma ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Quest Diagnostics (NYSE: DGX), a leader in ...

Test to be available for clinical and research use as soon as this summer, building on Quest's pioneering blood-based AD-Detect™ product line for assessing symptomatic patients SECAUCUS, N.J., July 9, ...

Please provide your email address to receive an email when new articles are posted on . Labcorp and Quest Diagnostics have both announced the availability of blood-based biomarker testing for ...

WHOOP, the human performance company, today announced that Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic ...

Performance wearable company Whoop is partnering with Quest Diagnostics to power Advanced Labs, a new feature that will track and analyze your bloodwork.

MADISON - Wisconsinites worried about "forever chemicals" now have a new way to test for levels in their blood. Quest Diagnostics released a new test for about $300 that will survey blood for nine ...

GRAND RAPIDS, Mich. (WOOD) — PFAS has been making headlines for years now, and based on everything we know about PFAS contamination, it will be several more years before the chemical exposure is ...